PO-0241 EAU eligibility criteria for exclusive 125I brachytherapy for intermediate risk prostate cancer von Robin, S., Chabaud, S., Serre, A., Bringeon, B., Clippe, S., Rocher, F., Desmettre, O., Bringeon, G., Gassa, F., Pommier, P.

Volltext

Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial von Benamouzig, Robert, Uzzan, Bernard, Deyra, Jacques, Martin, Antoine, Girard, Bernard, Little, Julian, Chaussade, Stanislas

Volltext

Cyclooxygenase-2 expression and recurrence of colorectal adenomas: effect of aspirin chemoprevention von Benamouzig, Robert, Uzzan, Bernard, Martin, Antoine, Deyra, Jacques, Little, Julian, Girard, Bernard, Chaussade, Stanislas

Volltext

Pancreatic metastasis from piriform sinus carcinoma von Ginies, F, Fontanges, T, Allagnat, B, Comte, D, Bringeon, B

Volltext

Métastase pancréatique révélatrice d'un carcinome du sinus piriforme von GINIES, F, FONTANGES, T, ALLAGNAT, B, COMTE, D, BRINGEON, B

Volltext

Pancreatic metastasis from piriform sinus carcinoma von Ginies, F, Fontanges, T, Allagnat, B, Comte, D, Bringeon, B

Volltext